Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lik Sprava ; (3-4): 72-4, 2003.
Artigo em Russo | MEDLINE | ID: mdl-12889364

RESUMO

Efficiency was studied of treatment of acute pneumonia (AP) in 148 patients with a focal croupous form. In the grave course of AP, antibacterial therapy with benzilpenicillin combined with sulphanilamide agents biseptol and nitrofuran was tried, the correcting therapy having been instituted on obtaining findings from assays of the sputum for sensitivity of the microflora to antibiotics. In those cases with Friendländer's bacilli recoverable, methicillin, oxacillin, macrolids, cephalosporins and some other agents were antibiotics of choice. Administered in the atypical course that was related more frequently to mycoplasms or chlamidia, was erythromycin phosphate i.v., lincomycin. In Staphylococcus-associated pneumonia, there have been used antibiotics resistant to penicillinases and endowed with an inhibitory activity toward staphylococci--oxacillin, methicillin, cephalosporins, chlorophenicols or chlorophphyllipt i.v. combined with an antistaphylacoccal plasma, antistaphylococcal gammaglobulin or hyperimmune plasma. The following drugs were prescribed to ensure bronchial patency and liquefaction of the sputum--euphyllin, mucalthin, bromhexin, lasolvan that are known to stimulate production of sulfoctant. The therapeutic complex comprized fibs, aloe, apilac, prodigiosan, solcoseryl, methyluracil known to stimulate bodily reactivity and resolution of inflammatory infiltration, nicotinic acid, heparin that have been shown to improve micorcirculation, tocopherol, unithiol known to regulate lipid oxidation. The data secured suggest to us a sufficient efficacy of the above-outlined therapy of AP.


Assuntos
Anti-Infecciosos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Pneumonia/tratamento farmacológico , Vasodilatadores/uso terapêutico , Doença Aguda , Adolescente , Adulto , Idoso , Humanos , Pessoa de Meia-Idade , Modalidades de Fisioterapia , Pneumonia/microbiologia , Pneumonia/fisiopatologia , Circulação Pulmonar/efeitos dos fármacos
3.
Lik Sprava ; (5-6): 147-9, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8630786

RESUMO

Prevalence was studied of subjects presenting with behavioral type A among patients with myocardial infraction (MI) of young age, personality traits of the cases and lipid content in each of the groups identified. In spite of certain methodological difficulties existing in diagnosis of behavioral type of a personality we did not find type A to be predominant among young MI cases. It was subjects with psychosthenic traits, lowered tolerance to stresses that tended to prevail among MI patients of young age.


Assuntos
Infarto do Miocárdio/psicologia , Personalidade , Personalidade Tipo A , Adulto , Humanos , Incidência , Lipídeos/sangue , Masculino , Infarto do Miocárdio/sangue , Infarto do Miocárdio/epidemiologia , Testes de Personalidade
4.
Lik Sprava ; (5-6): 119-21, 1993.
Artigo em Russo | MEDLINE | ID: mdl-8209471

RESUMO

241 patients at the age of 22-41 with primary myocardial infarction (MI) and 51 patients who previously had recurrent MI have been examined. Rate of the principal generally accepted risk factors as well as blood group, professional, characterological, nutritional and other peculiarities being able to effect IM incidence were analyzed. The likelihood of primary and recurrent MI was found to be significantly connected with arterial hypertension (AH), hereditary burden, hypercholesteremia, stenocardia, astenoneurotic syndrome. The probability of myocardial infarction, especially of recurrent one, is increased in patients associating AH with stenocardia, hereditary burden with astenoneurotic syndrome, AH with hypercholesteremia, physical and nervous overstrain.


Assuntos
Infarto do Miocárdio/epidemiologia , Adulto , Suscetibilidade a Doenças , Feminino , Humanos , Masculino , Infarto do Miocárdio/etiologia , Recidiva , Fatores de Risco , Fatores de Tempo , Ucrânia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...